Replies to post #1169 on Enanta Pharmaceuticals Inc (ENTA)

[NY1972]

If Harvoni will remain GILD’s preferred treatment for GT1 patients, what impact this 12-week regimen of Sovaldi/Velpatasvir will have on V Pak?

[north40000]

Do you have the same or different answers to Randy's question now, in light of what you posted?